Search clinical trials for: Placebo (for Vatelizumab)
Total 69790 results
-
Genzyme, a Sanofi CompanyTerminatedRelapsing-remitting Multiple SclerosisSweden, Poland, Russian Federation, United States, Canada
-
SanofiTerminatedUlcerative ColitisUnited States, Austria, Canada, France, Germany, Italy, Poland
-
BiogenCompletedRelapsing-Remitting Multiple SclerosisFrance, Italy, Spain, Germany, Belgium
-
BiogenCompletedAcute Ischemic StrokeSpain, United States, Germany, United Kingdom
-
BiogenTerminatedSecondary Progressive Multiple SclerosisUnited States, Finland, Italy, Spain, Canada, France, Israel, Sweden, Netherlands, Belgium, Poland, United Kingdom, Czechia, Denmark, Russian Federation, Germany, Ireland
-
BiogenCompletedAcute Ischemic StrokeSpain, United States, Germany
-
BiogenCompleted
-
Materia Medica HoldingCompletedAcute Upper Respiratory InfectionsRussian Federation
-
BiogenElan Pharmaceuticals; United BioSource, LLCCompleted
-
Genzyme, a Sanofi CompanyTerminatedRelapsing-remitting Multiple SclerosisRussian Federation, United States, Canada, Poland
-
SanofiTerminatedUlcerative ColitisUnited States
-
BiogenElan PharmaceuticalsTerminatedRheumatoid ArthritisUnited States, Canada
-
BiogenElan PharmaceuticalsCompleted
-
BiogenCompletedEpilepsy, Focal Seizures, Partial SeizuresUnited States
-
BiogenElan PharmaceuticalsWithdrawn
-
BiogenElan PharmaceuticalsCompletedCrohn's DiseaseUnited States
-
BiogenCompletedRelapsing-Remitting Multiple SclerosisBelgium, Germany, Italy, Norway, France, Mexico, Australia, Spain, Portugal, Greece, Netherlands, United Kingdom, Czechia, Slovakia, Finland, Canada, Argentina, Brazil
-
BiogenCompletedRelapsing-Remitting Multiple SclerosisCzechia, Belgium
-
BiogenTerminated
-
BiogenElan PharmaceuticalsCompletedMultiple Sclerosis, Relapsing-RemittingUnited Kingdom, United States, Canada, Belgium, Czech Republic, France, Germany, Netherlands
-
BiogenElan PharmaceuticalsCompletedCrohn's DiseaseUnited States
-
BiogenElan PharmaceuticalsCompletedCrohn's DiseaseUnited States, United Kingdom
-
University at BuffaloCompleted
-
University of South FloridaCompletedMultiple SclerosisUnited States
-
BiogenElan PharmaceuticalsCompletedRelapsing Remitting Multiple Sclerosis (RRMS)Belgium, Mexico, Poland, Romania, Saudi Arabia, Ukraine
-
BiogenCompletedRelapsing Multiple SclerosisUnited States, Puerto Rico
-
University Hospital, CaenBiogenCompletedMultiple Sclerosis, Relapsing-RemittingFrance
-
BiogenCompletedRelapsing-Remitting Multiple SclerosisIreland
-
BiogenElan PharmaceuticalsCompleted
-
BiogenCompletedRelapsing-Remitting Multiple Sclerosis
-
EnnovaBio Australia Pharmaceuticals Pty LtdNot yet recruiting
-
BiogenTerminatedRelapsing Multiple SclerosisBelgium
-
BiogenTerminatedCrohn's DiseaseUnited States, Puerto Rico
-
BiogenCompletedRelapsing-Remitting Multiple SclerosisUnited States
-
BiogenCompleted
-
Cornerstone Health Care, PABiogenCompletedMultiple Sclerosis, Relapsing-RemittingUnited States
-
ZYUS Life Sciences Inc.Novotech (Australia) Pty Limited; ZYUS Life Sciences Australia Pty LtdCompletedHealthy | OsteoarthritisAustralia
-
Innovent Biologics (Suzhou) Co. Ltd.RecruitingHealthy Participants | Atopic Dermatitis PatientsChina
-
King's College LondonSouth London and Maudsley NHS Foundation TrustCompleted
-
BiogenElan PharmaceuticalsCompletedMultiple Sclerosis, Relapsing-Remitting
-
BiogenTerminatedRelapsing Multiple SclerosisUnited States
-
BiogenElan PharmaceuticalsCompletedCrohn's DiseaseUnited States, Canada
-
BiogenCompletedMultiple Sclerosis | Relapsing-Remitting Multiple SclerosisJapan
-
BiogenCompletedRelapsing Forms of Multiple SclerosisUnited States
-
Nantes University HospitalRennes University HospitalActive, not recruiting
-
Theravance BiopharmaCompleted
-
Chong Kun Dang PharmaceuticalRecruitingPrimary HypercholesterolemiaKorea, Republic of
-
Spero TherapeuticsSimbec ResearchCompletedHealthy VolunteersUnited Kingdom
-
BiogenElan PharmaceuticalsTerminated